NEGLIGENCE IN COVID-19 VACCINE IN VIETNAM: THE PROVISIONS AND CHALLENGES
Main Article Content
Keywords
Abstract
Following the high level of COVID infections in Vietnam, the country has had many vaccinations to curb the rapid infections. Due to immediate vaccinations, the Government has encountered several damages due to the vaccines. However, due to the uniqueness of this event, the country has not been properly equipped to handle these damages. A lack of elaborate policies covering groups demonstrating hesitancy in accepting the vaccine leaves the group vulnerable to a lack of effective representation. Current legal mandates following the allocation of COVID-19 vaccines highlight clear signals for the availability of effective immunization support and an array of vaccine infrastructure resources. Determining the severity of health requires a combination of expertise in the medical field. Besides we can also refer to the levels of health damage considered severe in some countries worldwide. The vaccine market in Vietnam is marred by costly research and development, low returns on investment, increased public scrutiny, and little supportive government policy. Even though mandates may limit public support and increase backlash, as noted among hesitancy cases with the vaccine allocation, implementing the approaches is essential for establishing lasting interventions.
Downloads
References
Civil Code of Vietnam 2015 Decree 104/2016/ND-CP Decree No. 104/2016/ND-CP. Nguyen Thi Bao Anh and Truong Kim Phung (2020). Professional liability insurance in medical examination and treatment: Inadequacies and solutions. Scientific Journal of Can Tho University, Volume 56, Issue 3D (2020): 258-262, pp. 258 Kathleen Michon. Medical Malpractice: Misdiagnosis and Delayed Diagnosis. Accessed on 29/9/2021 at https://www.nolo.com/legal-encyclopedia/medical-malpractice-misdiagnosis-delayed-diagnosis-32288.html Chen, L.H. and Wilson, M.E., 2015. Medical tourism. Journal of travel medicine, 22(3), pp.218- 218. Crooks, V.A., Turner, L., Cohen, I.G., Bristeir, J., Snyder, J., Casey, V. and Whitmore, R., 2013. Ethical and legal implications of the risks of medical tourism for patients: a qualitative study of Canadian health and safety representatives’ perspectives. BMJ open, 3(2), p.e002302. Gulati, S., 2021. Decoding the global trend of “vaccine tourism” through public sentiments and emotions: does it get a nod on Twitter?. Global Knowledge, Memory and Communication. Gostin, L. O., Salmon, D. A., & Larson, H. J. (2021). Mandating COVID-19 vaccines. Jama, 325(6), 532-533. Helble, M., Park, C.Y. and Won, H.C., 2021. Can Vaccination Help Restart Tourism?. Hopkins, L., Labonté, R., Runnels, V. and Packer, C., 2010. Medical tourism today: what is the state of existing knowledge?. Journal of public health policy, 31(2), pp.185-198. Kim, J. H., Marks, F., & Clemens, J. D. (2021). Looking beyond COVID-19 vaccine phase 3 trials. Nature medicine, 27(2), 205-211. Khubchandani, J., Sharma, S., Price, J. H., Wiblishauser, M. J., Sharma, M., & Webb, F. J. (2021). COVID-19 vaccination hesitancy in the United States: a rapid national assessment. Journal of Community Health, 46(2), 270-277. Lazarus, J. V., Ratzan, S. C., Palayew, A., Gostin, L. O., Larson, H. J., Rabin, K., ... & ElMohandes, A. (2021). A global survey of potential acceptance of a COVID-19 vaccine. Nature medicine, 27(2), 225-228. Noree, T., Hanefeld, J. and Smith, R., 2016. Medical tourism in Thailand: a cross-sectional study. Bulletin of the World Health Organization, 94(1), p.30. Volpp, K. G., Loewenstein, G., & Buttenheim, A. M. (2021). Behaviorally informed strategies for a national COVID-19 vaccine promotion program. JAMA, 325(2), 125-126
